Copyright
©The Author(s) 2021.
World J Gastroenterol. Apr 28, 2021; 27(16): 1805-1815
Published online Apr 28, 2021. doi: 10.3748/wjg.v27.i16.1805
Published online Apr 28, 2021. doi: 10.3748/wjg.v27.i16.1805
Figure 1 Eca-109 cell viability following treatment with CPI-455 at different times and concentrations.
Data are expressed as means ± SE (n = 3). aP < 0.05 vs control.
- Citation: Xue XJ, Li FR, Yu J. Mitochondrial pathway of the lysine demethylase 5C inhibitor CPI-455 in the Eca-109 esophageal squamous cell carcinoma cell line. World J Gastroenterol 2021; 27(16): 1805-1815
- URL: https://www.wjgnet.com/1007-9327/full/v27/i16/1805.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i16.1805